MARKET ANALYS OF ICONOVO BY ERIK PENSER BANK (ONLY IN SWEDISH)
Analys från Penser access:
Iconovo - Tar klivet in i USA genom ny plattform. Läs mera här
PRESS RELEASE, 25 October 2019
Iconovo AB (publ) makes a significant investment in the development of a new inhalation platform
Iconovo AB (publ) announced today that the company has…
ICONOVO’S WEAPON IN THE FIGHT AGAINST ASTHMA
Asthma has long been a significant global health issue and the problem only appears to grow. This summer a report from Asthma UK showed a marked increase…
CLINICAL PROGRESS UPS THE VALUE OF ICONOVO’S FLAGSHIP PROJECT
Lund based Iconovo did not sit still during the summer, instead the company released the biggest news of the year thus far. in mid-July, Iconovo announced…
MARKET ANALYS OF ICONOVO BY ERIK PENSER BANK (ONLY IN SWEDISH)
Positivt kliniskt resultat ger höjd riktkurs. Läs mera här
Positive results from Clinical Study with ICOres
Iconovo AB (publ) together with Amneal Pharmaceuticals Company GmbH and CBC Corporation India Pvt Ltd (fully owned subsidiary of CBC Co. Ltd, Japan)…
Perfect Design: DPI Devices from Iconovo
Iconovo specializes in the product development of customized DPI devices – and utilizes an integrated approach.
Cross-border networking as a recipe for…
New member of the Board May 2019
Iconovo welcomes Dr. Agneta Walhagen as new member of the Board of Directors at Iconovo.
Agneta has over 26 years of experience working within research…
MARKET ANALYS OF ICONOVO BY ERIK PENSER BANK (ONLY IN SWEDISH)
Analys från Penser access:
Iconovo - USA-marknaden öppnar upp sig. Läs vidare här
Iconovo mentioned in Biostock (only in Swedish)
Starkt första kvartal för Iconovo
Inhalationsbolaget Iconovos första kvartal 2019 kan väsentligen sammanfattas med en större bokförd intäktspost,…